Low circulating soluble interleukin 2 receptor level predicts rapid response in patients with refractory rheumatoid arthritis treated with infliximab.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/FF419FD8.svg?ark=w1%2F20260515%2FFF419FD8)](https://nobleid.org/work/w1/20260515/FF419FD8)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors